187 related articles for article (PubMed ID: 32183748)
21. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
[TBL] [Abstract][Full Text] [Related]
24. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients.
Yeung HW; Schöder H; Smith A; Gonen M; Larson SM
Mol Imaging Biol; 2005; 7(3):229-35. PubMed ID: 15912427
[TBL] [Abstract][Full Text] [Related]
26. Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure.
Wang YJ; Baratto L; Hawk KE; Theruvath AJ; Pribnow A; Thakor AS; Gatidis S; Lu R; Gummidipundi SE; Garcia-Diaz J; Rubin D; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2771-2781. PubMed ID: 33527176
[TBL] [Abstract][Full Text] [Related]
27.
Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
Arens AI; Postema JW; Schreurs WM; Lafeber A; Hendrickx BW; Oyen WJ; Vogel WV
PLoS One; 2016; 11(8):e0160539. PubMed ID: 27556809
[TBL] [Abstract][Full Text] [Related]
29. Head and Neck Cancer Segmentation in FDG PET Images: Performance Comparison of Convolutional Neural Networks and Vision Transformers.
Xiong X; Smith BJ; Graves SA; Graham MM; Buatti JM; Beichel RR
Tomography; 2023 Oct; 9(5):1933-1948. PubMed ID: 37888743
[TBL] [Abstract][Full Text] [Related]
30. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Schöder H; Yeung HW; Gonen M; Kraus D; Larson SM
Radiology; 2004 Apr; 231(1):65-72. PubMed ID: 14990824
[TBL] [Abstract][Full Text] [Related]
31. Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
Casselden E; Sheerin F; Winter SC
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):243-247. PubMed ID: 30535976
[TBL] [Abstract][Full Text] [Related]
32. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
[TBL] [Abstract][Full Text] [Related]
33.
Abadi P; Johansen A; Godballe C; Gerke O; Høilund-Carlsen PF; Thomassen A
Ann Nucl Med; 2017 Feb; 31(2):101-108. PubMed ID: 27921286
[TBL] [Abstract][Full Text] [Related]
34. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
35. Chest radiography or chest CT plus head and neck CT versus
Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
37. Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
Kirchner J; Sawicki LM; Suntharalingam S; Grueneisen J; Ruhlmann V; Aktas B; Deuschl C; Herrmann K; Antoch G; Forsting M; Umutlu L
PLoS One; 2017; 12(2):e0172553. PubMed ID: 28225831
[TBL] [Abstract][Full Text] [Related]
38. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN
J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854
[TBL] [Abstract][Full Text] [Related]
39. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
40. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P
J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]